Arthritis Market Research Reports

Arthritis Market Research

The research reports provide a detailed analysis of the most updated technology trends and developments in the global Arthritis therap... view more

TITLE Price Buy Now More options

Arthritis Therapeutics Market to 2018 – Novel Oral JAK Inhibitors and Biologic Disease Modifying Anti-Rheumatic Drugs (DMARD) Will Drive Continued Growth Across Key Indications GBI Research’s new report, Arthritis Therapeutics Market to 2018 – Disease Modifying Anti-rheumatic Drugs Revolutionize Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis”, provides an expert...	$ 3500
Rheumatoid Arthritis Drugs Market in Japan 2011-2015 TechNavio's analysts forecast the Rheumatoid Arthritis market in Japan to grow at a CAGR of 29.2 percent over the period 2011-2015. One of the key factors contributing to this market growth is the high prevalence rate of patients suffering fro...	$ 1500
Global Rheumatoid Arthritis Drugs Market 2011-2015 TechNavio’s analysts forecast the Global Rheumatoid Arthritis Drugs market to grow at a CAGR of 12.1 percent over the period 2011–2015. One of the key factors contributing to this market growth is the high incidence and prevalence rate...	$ 1500
Product Profiles: Disease Modification in Rheumatoid Arthritis – Game-changing therapy close to market Report SummaryThe potential for Pfizer’s tofacitinib (CP-690,550) to drive a paradigm change in rheumatoid arthritis treatment edges closer, with news in 2011 that US, EU, and Japanese regulatory agencies are re...	$ 11400
The World Market for Prescription Arthritis Treatments Report SummaryArthritis is one of the most common human ailments worldwide. Arthritis is a complex family of musculoskeletal disorders with many causes that are not fully understood. The most crippling of the arthriti...	$ 3500
Anti-Inflammatory Therapeutics Market to 2017 - Respiratory Diseases and Arthritis Continue to Dominate Report SummaryGBI Research, the leading business intelligence provider, has released its latest research, Anti-Inflammatory Therapeutics Market to 2017 - Respiratory Diseases and Arthritis Continue to Dominate”...	$ 3500
Rheumatoid Arthritis Therapeutics - Pipeline Assessment and Market Forecasts to 2018 GlobalData, the industry analysis specialist, has released its new report, Rheumatoid Arthritis Therapeutics - Pipeline Assessment and Market Fo...	$ 3500
R&D Trends: Rheumatoid Arthritis - Approaching an era of novel kinase inhibitors IntroductionDatamonitor has identified a total of 153 products in development for rheumatoid arthritis. There is considerable interest in kinase inhibitors in the rheumatology field and they remain p...	$ 3800
Opioids Market to 2017 - Steady Uptake of Oxycontin and High Incidence Of Diseases Such As Cancer And Arthritis to Drive the Market GBI Research, the leading business intelligence provider, has released its latest research, Opioids Market to 2017 - Steady Uptake of Oxycontin and High Incidence Of Diseases Suc...	$ 3500
U.S. Rheumatoid Arthritis Market: Assessment of Biologics and New Treatments This research service covers the U.S. rheumatoid arthritis (RA) market from 2007 to 2017, with 2010 as the base year. Included in this research service are products currently in the market, products in development, and patient forecasts. Ma...	$ 6000
Juvenile Rheumatoid Arthritis (JRA) Therapeutics - Pipeline Assessment and Market Forecasts to 2017 GlobalData, the industry analysis specialist, has released its new report, Juvenile Rheumatoid Arthritis (JRA) Therapeutics - Pipeline Ass...	$ 2000
Epidemiology: Rheumatoid Arthritis Globally, between 0.2% and 1.2% of the world population above the age of 16 years has rheumatoid arthritis. In 2010, there were approximately 4.6 million people with rheumatoid arthritis in the seven ma...	$ 5700
Rheumatoid Arthritis Market Forecast IntroductionIn 2009, TNF inhibitors were the dominant drug class in terms of sales. However, there is growing use of non-TNF biologics at earlier lines of treatment, and this trend will continue over the next decade. With the fi...	$ 15200
Commercial Insight: Disease Modification in Rheumatoid Arthritis – Market awaits game changing therapies and strategies IntroductionIn 2009, TNF inhibitors were the dominant drug class in terms of sales. However, there is growing use of non-TNF biologics at earlier lines of treatment, and this trend will continue over the next decade. With the fi...	$ 15200
Rheumatoid Arthritis - Pipeline Assessment and Market Forecasts to 2017 GlobalData, the industry analysis specialist, has released a new report, ”. The report is an essential source of information and a...	$ 2000
Arthritis Therapeutics Market to 2016 - Biologics Revolutionize Treatment of Rheumatoid Arthritis and Psoriatic Arthritis GBI Research’s new report, Arthritis Therapeutics Market to 2016 - Biologics Revolutionize Treatment of Rheumatoid Arthritis (RA) and Psoriatic Arthritis (PsA)”, provides in-depth analysis o...	$ 3500
Musculoskeletal Disorders Therapeutics to 2016 - Introduction of Monoclonal Antibodies with First - in - class Mechanism of Action to Increase Treatment Options in Osteoporosis and Rheumatoid Arthritis GBI Research’s report, Musculoskeletal Therapeutics to 2016 - Introduction of Monoclonal Antibodies with First-in-class Mechanism of Action to Increase Treatment Options in Osteoporosis and Rheuma...	$ 3500
Stakeholder Insight: Rheumatoid arthritis - Rising competition by line and severity IntroductionDisease-modifying antirheumatic drugs (DMARDs) underpin the current management of rheumatoid arthritis. This will likely remain unchanged over the next decade. In spite of high costs, rheumatologists perceive th...	$ 15200
Rheumatoid Arthritis - Drug Pipeline Analysis and Market Forecasts to 2015 GlobalData, the industry analysis specialist, has released a new report on the Pharmaceutical and Healthcare industry, Rheumatoid Arthriti...	$ 2000
Chinese Markets for Arthritis Treatment Drugs China's demand for Arthritis Treatment Drugs has grown at a fast pace in the past decade. In the next five years, both production and demand will continue to grow. This new study examines China's...	$ 4000

First

Last

Live Chat Support

Connect With Us

Email: sales@reportsandreports.com Call : + 1 888 391 5441

Subscription Option

Use our subscription option and keep yourself updated about the latest industry analysis reports. We have research reports for over 5000 micro markets; you can access and utilize them at economical budgets.

More about our Subscription option

Email Alerts

Get Email alerts about market research reports from industries and publishers of your interest: